Systemic Lupus Erythematosus

A cricoarytenoid arthritis  hoarseness, stridor, or airway obstruction (awake

intubation), post-extubation edema
B effusion, pneumonitis, pul HTN, and alveolar hemorrhage. high correlation
of pul HTN with Raynaud's phenomenon in patients with SLE.(CXR, PFT)
C pericardial effusion, tamponade, Cardiomyopathy, cardiac conduction
abnormalities,  ventricular function, and coronary arteritis, noninfectious
endocarditis (Libman-Sacks endocarditis)  mitral insufficiency (ECG, ECHO)
D immunosuppressants (corticosteroids) or cytotoxic drugs
(cyclophosphamide, azathioprine, cyclosporine),avoid Drug-induced lupus
quinidine, hydralazine, methyldopa, captopril, enalapril, clonidine, isoniazid,
Hanti-phospholipid antibodies  thromboembolic complications, anemia
R common cause of M&M in patients with SLE, CRF
CNS seizures, stroke, dementia, psychosis, and peripheral neuropathy
GI peritonitis, pancreatitis, bowel ischemia, protein-losing enteropathy, and
lupoid hepatitis